DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer

Information source: Bristol-Myers Squibb
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cancer; Breast Cancer

Intervention: Ixabepilone + Capecitabine (Drug); Capecitabine (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: Bristol-Myers Squibb

Official(s) and/or principal investigator(s):
Bristol-Myers Squibb, Study Director, Affiliation: Bristol-Myers Squibb

Summary

The purpose of this clinical research study is to learn if BMS-247550 added to the approved therapy of capecitabine (Xeloda) provides measurable clinical benefits over capecitabine alone in women with metastatic breast cancer. Patients should have previously received an anthracycline and a taxane. The safety of this treatment will also be studied.

Clinical Details

Official title: A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane

Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: Overall Survival from Date of Randomization to Death

Secondary outcome:

Time To Progression

Response Rate and Duration of Response in patients with Measureable disease

Quality of Life

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Female.

Criteria:

- Patients must have received prior treatment which included both an anthracycline

(i. e., doxorubicin or epirubicin) and a taxane (i. e., paclitaxel or docetaxel).

- Patients must have received no more than two prior chemotherapy regimens. Patients

who have not received treatment for metastatic disease must have relapsed within one year.

- Patients may not have any history of brain and/or leptomeningeal metastases.

- Patients may not have Grade 2 or worse neuropathy at the time of study entry.

- Patients may not have had prior treatment with any epothilones and/or capecitabine

(i. e. Xeloda)

Locations and Contacts

Local Institution, Buenos Aires, Argentina

Local Institution, Buenos Aires, Argentina

Local Institution, Buenos Aires, Argentina

Local Institution, Mendoza, Argentina

Local Institution, Salta, Argentina

Local Institution, Santa Fe, Argentina

Local Institution, Wien, Austria

Local Institution, Wien, Austria

Local Institution, Graz, Austria

Local Institution, Voecklabruck, Austria

Local Institution, charleroi, Belgium

Local Institution, bruxelles, Belgium

Local Institution, wilrijk, Belgium

Local Institution, Kortrijk, Belgium

Local Institution, Hasselt, Belgium

Local Institution, Gent, Belgium

Local Institution, Rio De Janeiro, Brazil

Local Institution, Beijing, China

Local Institution, Beijing, China

Local Institution, Beijing, China

Local Institution, Beijing, China

Local Institution, Shanghai, China

Local Institution, Split, Croatia

Local Institution, Zagreb, Croatia

Local Institution, Zagreb, Croatia

Local Institution, Prague, Czech Republic

Local Institution, Prague, Czech Republic

Local Institution, Brno, Czech Republic

Local Institution, Hradec Kralove, Czech Republic

Local Institution, Prague 5, Czech Republic

Local Institution, Aalborg, Denmark

Local Institution, Kobenhavn O, Denmark

Local Institution, Herlev, Denmark

Local Institution, Paris Cedex 13, France

Local Institution, Villejuif Cedex, France

Local Institution, Colmar, France

Local Institution, Caen, France

Local Institution, Pierre Benite, France

Local Institution, Bordeaux, France

Local Institution, Tours Cedex, France

Local Institution, Metz, France

Local Institution, Le Mans, France

Local Institution, Reims, France

Local Institution, Saint Gregoire, France

Local Institution, Saint Herblain, France

Local Institution, Clermont-Ferrand, France

Local Institution, Angers, France

Local Institution, Saint Brieuc, France

Local Institution, Munchen, Germany

Local Institution, Berlin, Germany

Local Institution, Ulm, Germany

Local Institution, Tubingen, Germany

Local Institution, Wiesbaden, Germany

Local Institution, Erlangen, Germany

Local Institution, Hannover, Germany

Local Institution, Kiel, Germany

Local Institution, Essen, Germany

Local Institution, Marburg, Germany

Local Institution, Karlsruhe, Germany

Local Institution, Rehling, Germany

Local Institution, Saarbrucken, Germany

Local Institution, Berlin, Germany

Local Institution, Patras, Greece

Local Institution, Crete, Greece

Local Institution, Athens, Greece

Local Institution, Thessaloniki, Greece

Local Institution, Thessaloniki, Greece

Local Institution, Galway, Ireland

Local Institution, Dublin 8, Ireland

Local Institution, Dublin, Ireland

Local Institution, Dublin 9, Ireland

Local Institution, Dublin, Ireland

Local Institution, Cork, Ireland

Local Institution, Tel Aviv, Israel

Local Institution, Jerusalem, Israel

Local Institution, Ramat-Gan, Israel

Local Institution, Haifa, Israel

Local Institution, Haifa, Israel

Local Institution, Roma, Italy

Local Institution, Modena, Italy

Local Institution, Firenze, Italy

Local Institution, Roma, Italy

Local Institution, Potenza, Italy

Local Institution, Genova, Italy

Local Institution, Perugia, Italy

Local Institution, Milano, Italy

Local Institution, Bari, Italy

Local Institution, Roma, Italy

Local Institution, Sora, Italy

Local Institution, Torino, Italy

Local Institution, San Giovanni Rotondo, Italy

Local Institution, Seoul, Korea, Republic of

Local Institution, Incheon, Korea, Republic of

Local Institution, Gyeonggi-Do, Korea, Republic of

Local Institution, Seoul, Korea, Republic of

Local Institution, Seoul, Korea, Republic of

Local Institution, Enschede, Netherlands

Local Institution, Den Haag, Netherlands

Local Institution, Zwolle, Netherlands

Local Institution, Arnhem, Netherlands

Local Institution, Coimbra, Portugal

Local Institution, Coimbra, Portugal

Local Institution, Lisboa, Portugal

Local Institution, St. Petersburg, Russian Federation

Local Institution, Moscow, Russian Federation

Local Institution, Moscow, Russian Federation

Local Institution, Kazan, Russian Federation

Local Institution, Kazan, Russian Federation

Local Institution, Singapore, Singapore

Local Institution, singapore, Singapore

Local Institution, Hospitalet De Llobregat, Spain

Local Institution, Tenerife, Spain

Local Institution, Salamanca, Spain

Local Institution, Elche (Alicante), Spain

Local Institution, Pontevedra, Spain

Local Institution, Valencia, Spain

Local Institution, Barcelona, Spain

Local Institution, Jaen, Spain

Local Institution, Madrid, Spain

Local Institution, Madrid, Spain

Local Institution, Cordoba, Spain

Local Institution, Sevilla, Spain

Local Institution, Zaragoza, Spain

Local Institution, Cadiz, Spain

Local Institution, madrid, Spain

Local Institution, Valencia, Spain

Local Institution, Sevilla, Spain

Local Institution, Reus, Spain

Local Institution, Bern, Switzerland

Local Institution, Zurich, Switzerland

Local Institution, Thun, Switzerland

Local Institution, Taipei, Taiwan

Local Institution, Taipei, Taiwan

Local Institution, Taipei, Taiwan

Local Institution, izmir, Turkey

Local Institution, istanbul, Turkey

Local Institution, Ankara, Turkey

Local Institution, Izmir, Turkey

Local Institution, Istanbul, Turkey

Local Institution, Tuscon, Arizona, United States

Local Institution, Belfast, Armagh, United Kingdom

Local Institution, Terassa, Barcelona, Spain

Local Institution, Bahia Blanca, Buenos Aires, Argentina

Local Institution, Ciudad Autonoma De Buenos Aires, Buenos Aires, Argentina

Local Institution, Avelianeda, Buenos Aires, Argentina

Local Institution, Escobar, Buenos Aires, Argentina

Local Institution, Bahia Blanca, Buenos Aires, Argentina

Local Institution, Beverly Hills, California, United States

Local Institution, Corona, California, United States

Local Institution, Glasgow, Central, United Kingdom

Local Institution, Resistencia, Chaco, Argentina

Local Institution, hartford, Connecticut, United States

Local Institution, Barrio Alto Verde, Cordoba, Argentina

Local Institution, Wilton, Cork, Ireland

Local Institution, Port Elizabeth, Eastern Cape, South Africa

Local Institution, plantation, Florida, United States

Local Institution, Johannesburg, Gauteng, South Africa

Local Institution, Johannesburg, Gauteng, South Africa

Local Institution, Pretoria, Gauteng, South Africa

Local Institution, Pretoria, Gauteng, South Africa

Local Institution, London, Greater London, United Kingdom

Local Institution, London, Greater London, United Kingdom

Local Institution, London, Greater London, United Kingdom

Local Institution, Guangzhou, Guangdong, China

Local Institution, Boise, Idaho, United States

Local Institution, Evanston, Illinois, United States

Local Institution, iowa city, Iowa, United States

Local Institution, Nanjing, Jiangsu, China

Local Institution, Nanjing, Jiangsu, China

Local Institution, Louisville, Kentucky, United States

Local Institution, Dalian, Liaoning, China

Local Institution, Dilian, Liaoning, China

Local Institution, Baton Rouge, Louisiana, United States

Local Institution, Bethesda, Maryland, United States

Local Institution, boston, Massachusetts, United States

Local Institution, Santiago, Metropolitana, Chile

Local Institution, Santiago, Metropolitana, Chile

Local Institution, Rozzano, Milan, Italy

Local Institution, Jackson, Mississippi, United States

Local Institution, Columbia, Missouri, United States

Local Institution, Voorhees, New Jersey, United States

Local Institution, albuquerque, New Mexico, United States

Local Institution, Sydney, New South Wales, Australia

Local Institution, Westmead, New South Wales, Australia

Local Institution, new york, New York, United States

Local Institution, Bronx, New York, United States

Local Institution, mineola, New York, United States

Local Institution, latham, New York, United States

Local Institution, hickory, North Carolina, United States

Local Institution, durham, North Carolina, United States

Local Institution, Goldsboro, North Carolina, United States

Local Institution, Kinston, North Carolina, United States

Local Institution, columbus, Ohio, United States

Local Institution, Canton, Ohio, United States

Local Institution, Thunder Bay, Ontario, Canada

Local Institution, langhorne, Pennsylvania, United States

Local Institution, Montreal, Quebec, Canada

Local Institution, South Brisbane, Queensland, Australia

Local Institution, Herston, Queensland, Australia

Local Institution, Toowoomba, Queensland, Australia

Local Institution, Brisbane, Queensland, Australia

Local Institution, Centro-Porto Alegre, Rio Grande Do Sul, Brazil

Local Institution, Higienopolis, Sao Paulo, Brazil

Local Institution, Bela Vista, Sao Paulo, Brazil

Local Institution, Xi'An, Shan3xi, China

Local Institution, Jinan, Shandong, China

Local Institution, Shrewsbury, Shropshire, United Kingdom

Local Institution, Woodville, South Australia, Australia

Local Institution, Adelaide, South Australia, Australia

Local Institution, Sao Paulo, Sp, Brazil

Local Institution, knoxville, Tennessee, United States

Local Institution, memphis, Tennessee, United States

Local Institution, knoxville, Tennessee, United States

Local Institution, Dallas, Texas, United States

Local Institution, San Miguel De Tucuman, Tucuman, Argentina

Local Institution, Parkville, Victoria, Australia

Local Institution, East Melbourne, Victoria, Australia

Local Institution, Richmond, Virginia, United States

Local Institution, Norfolk, Virginia, United States

Local Institution, Charlottesville, Virginia, United States

Local Institution, Birmingham, West Midlands, United Kingdom

Local Institution, Perth, Western Australia, Australia

Local Institution, Panorama, Western Cape, South Africa

Local Institution, marshfield, Wisconsin, United States

Local Institution, Hangzhou, Zhejiang, China

Local Institution, Hangzhou, Zhejiang, China

Additional Information

BMS Clinical Trials Disclosure

For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm

Starting date: November 2003
Ending date: April 2008
Last updated: May 14, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012